Mustafa Khasraw
Mustafa Khasraw
Verified email at duke.edu
Title
Cited by
Cited by
Year
Advances in the treatment of malignant gliomas
M Khasraw, AB Lassman
Current oncology reports 12 (1), 26-33, 2010
1382010
Longitudinal molecular trajectories of diffuse glioma in adults
FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ...
Nature 576 (7785), 112-120, 2019
1292019
Antiangiogenic therapy for high‐grade glioma
M Khasraw, MS Ameratunga, R Grant, H Wheeler, N Pavlakis
Cochrane Database of Systematic Reviews, 2014
1252014
Epirubicin: is it like doxorubicin in breast cancer? A clinical review
M Khasraw, R Bell, C Dang
The Breast 21 (2), 142-149, 2012
1212012
Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance
DLH Chan, N Pavlakis, GP Schembri, EJ Bernard, E Hsiao, A Hayes, ...
Theranostics 7 (5), 1149, 2017
1082017
Management of glioblastoma: State of the art and future directions
AC Tan, DM Ashley, GY López, M Malinzak, HS Friedman, M Khasraw
CA: a cancer journal for clinicians 70 (4), 299-312, 2020
992020
Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
ST Garber, Y Hashimoto, SP Weathers, J Xiu, Z Gatalica, RGW Verhaak, ...
Neuro-oncology 18 (10), 1357-1366, 2016
972016
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
A Omuro, TA Chan, LE Abrey, M Khasraw, AS Reiner, TJ Kaley, ...
Neuro-oncology 15 (2), 242-250, 2013
922013
EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model
T Wang, MP Gantier, D Xiang, AG Bean, M Bruce, SF Zhou, M Khasraw, ...
Theranostics 5 (12), 1456, 2015
852015
Adaptive global innovative learning environment for glioblastoma: GBM AGILE
BM Alexander, S Ba, MS Berger, DA Berry, WK Cavenee, SM Chang, ...
Clinical Cancer Research 24 (4), 737-743, 2018
802018
Neurological complications of systemic cancer
M Khasraw, JB Posner
The Lancet Neurology 9 (12), 1214-1227, 2010
742010
Machine-learning prediction of cancer survival: a retrospective study using electronic administrative records and a cancer registry
S Gupta, T Tran, W Luo, D Phung, RL Kennedy, A Broad, D Campbell, ...
BMJ open 4 (3), e004007, 2014
662014
Intracranial hemorrhage in patients with cancer treated with bevacizumab: the Memorial Sloan-Kettering experience
M Khasraw, A Holodny, SA Goldlust, LM DeAngelis
Annals of oncology 23 (2), 458-463, 2012
652012
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
M Khasraw, N Pavlakis, S McCowatt, C Underhill, S Begbie, P de Souza, ...
Annals of oncology 21 (6), 1302-1307, 2010
562010
Anti‐angiogenic therapy for high‐grade glioma
M Ameratunga, N Pavlakis, H Wheeler, R Grant, J Simes, M Khasraw
Cochrane Database of Systematic Reviews, 2018
492018
Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian Gastro-Intestinal …
E Segelov, S Thavaneswaran, PM Waring, J Desai, KP Robledo, ...
Journal of Clinical Oncology 34 (19), 2258-2264, 2016
452016
The need to examine metastatic tissue at the time of progression of breast cancer: is re-biopsy a necessity or a luxury?
M Khasraw, E Brogi, AD Seidman
Current oncology reports 13 (1), 17-25, 2011
452011
Using lithium as a neuroprotective agent in patients with cancer
M Khasraw, D Ashley, G Wheeler, M Berk
BMC medicine 10 (1), 1-7, 2012
442012
Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium
Neuro-oncology 20 (7), 873-884, 2018
432018
Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer
SM Domchek, K Jhaveri, S Patil, JE Stopfer, C Hudis, J Powers, Z Stadler, ...
Cancer 119 (7), 1344-1348, 2013
422013
The system can't perform the operation now. Try again later.
Articles 1–20